223 related articles for article (PubMed ID: 1972759)
1. Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene.
Groner Y; Elroy-Stein O; Avraham KB; Yarom R; Schickler M; Knobler H; Rotman G
J Physiol (Paris); 1990; 84(1):53-77. PubMed ID: 1972759
[TBL] [Abstract][Full Text] [Related]
2. Cell damage by excess CuZnSOD and Down's syndrome.
Groner Y; Elroy-Stein O; Avraham KB; Schickler M; Knobler H; Minc-Golomb D; Bar-Peled O; Yarom R; Rotshenker S
Biomed Pharmacother; 1994; 48(5-6):231-40. PubMed ID: 7999984
[TBL] [Abstract][Full Text] [Related]
3. Impaired neurotransmitter uptake in PC12 cells overexpressing human Cu/Zn-superoxide dismutase--implication for gene dosage effects in Down syndrome.
Elroy-Stein O; Groner Y
Cell; 1988 Jan; 52(2):259-67. PubMed ID: 2893664
[TBL] [Abstract][Full Text] [Related]
4. Down's syndrome: abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn-superoxide dismutase.
Avraham KB; Schickler M; Sapoznikov D; Yarom R; Groner Y
Cell; 1988 Sep; 54(6):823-9. PubMed ID: 2970304
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice overexpressing the human Cu/Zn-SOD gene: ultrastructural studies of a premature thymic involution model of Down's syndrome (trisomy 21).
Nabarra B; Casanova M; Paris D; Nicole A; Toyama K; Sinet PM; Ceballos I; London J
Lab Invest; 1996 Mar; 74(3):617-26. PubMed ID: 8600312
[TBL] [Abstract][Full Text] [Related]
6. Clinical symptoms of Down syndrome are manifested in transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene.
Groner Y; Avraham KB; Schickler M; Yarom R; Knobler H
Prog Clin Biol Res; 1990; 360():233-62. PubMed ID: 2147288
[No Abstract] [Full Text] [Related]
7. Premature aging changes in neuromuscular junctions of transgenic mice with an extra human CuZnSOD gene: a model for tongue pathology in Down's syndrome.
Yarom R; Sapoznikov D; Havivi Y; Avraham KB; Schickler M; Groner Y
J Neurol Sci; 1988 Dec; 88(1-3):41-53. PubMed ID: 2976083
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth.
Zhang Y; Zhao W; Zhang HJ; Domann FE; Oberley LW
Cancer Res; 2002 Feb; 62(4):1205-12. PubMed ID: 11861405
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome.
Epstein CJ; Avraham KB; Lovett M; Smith S; Elroy-Stein O; Rotman G; Bry C; Groner Y
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8044-8. PubMed ID: 2960971
[TBL] [Abstract][Full Text] [Related]
10. [Transgenic mice overexpressing copper-zinc superoxide dismutase: a model for the study of radical mechanisms and aging].
Ceballos-Picot I
C R Seances Soc Biol Fil; 1993; 187(3):308-23. PubMed ID: 8019910
[TBL] [Abstract][Full Text] [Related]
11. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
Annerén G; Edman B
APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
[TBL] [Abstract][Full Text] [Related]
12. Gene dosage of CuZnSOD and Down's syndrome: diminished prostaglandin synthesis in human trisomy 21, transfected cells and transgenic mice.
Minc-Golomb D; Knobler H; Groner Y
EMBO J; 1991 Aug; 10(8):2119-24. PubMed ID: 1829676
[TBL] [Abstract][Full Text] [Related]
13. Diminished serotonin uptake in platelets of transgenic mice with increased Cu/Zn-superoxide dismutase activity.
Schickler M; Knobler H; Avraham KB; Elroy-Stein O; Groner Y
EMBO J; 1989 May; 8(5):1385-92. PubMed ID: 2527742
[TBL] [Abstract][Full Text] [Related]
14. Radiation sensitivity of Down's syndrome fibroblasts might be due to overexpressed Cu/Zn-superoxide dismutase (EC 1.15.1.1).
Schwaiger H; Weirich HG; Brunner P; Rass C; Hirsch-Kauffmann M; Groner Y; Schweiger M
Eur J Cell Biol; 1989 Feb; 48(1):79-87. PubMed ID: 2526018
[TBL] [Abstract][Full Text] [Related]
15. Cellular clones and transgenic mice overexpressing copper-zinc superoxide dismutase: models for the study of free radical metabolism and aging.
Ceballos-Picot I; Nicole A; Sinet PM
EXS; 1992; 62():89-98. PubMed ID: 1450608
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the human CuZnSOD gene in transfected cells--implication to Down syndrome.
Elroy-Stein O; Bernstein Y; Avraham KB; Dafni N; Levanon D; Danciger E; Neer A; Groner Y
Prog Clin Biol Res; 1987; 253():373-92. PubMed ID: 2963346
[No Abstract] [Full Text] [Related]
17. Increased superoxide dismutase and Down's syndrome.
Turrens JF
Med Hypotheses; 2001 Jun; 56(6):617-9. PubMed ID: 11399108
[TBL] [Abstract][Full Text] [Related]
18. Autoradiographic distribution of [3H]neurotensin receptors in the brains of superoxide dismutase transgenic mice.
Cadet JL; Kujirai K; Carlson E; Epstein CJ
Synapse; 1993 May; 14(1):24-33. PubMed ID: 8390106
[TBL] [Abstract][Full Text] [Related]
19. Down's syndrome: morphological remodelling and increased complexity in the neuromuscular junction of transgenic CuZn-superoxide dismutase mice.
Avraham KB; Sugarman H; Rotshenker S; Groner Y
J Neurocytol; 1991 Mar; 20(3):208-15. PubMed ID: 1828079
[TBL] [Abstract][Full Text] [Related]
20. Functional and morphological alterations in compound transgenic mice overexpressing Cu/Zn superoxide dismutase and amyloid precursor protein [correction].
Harris-Cerruti C; Kamsler A; Kaplan B; Lamb B; Segal M; Groner Y
Eur J Neurosci; 2004 Mar; 19(5):1174-90. PubMed ID: 15016076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
